Literature DB >> 12947048

Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.

Robert C Gensure1, Naoto Shimizu, Janet Tsang, Thomas J Gardella.   

Abstract

Recent functional studies have suggested that position 19 in PTH interacts with the portion of the PTH-1 receptor (P1R) that contains the extracellular loops and seven transmembrance helices (TMs) (the J domain). We tested this hypothesis using the photoaffinity cross-linking approach. A PTHrP(1-36) analog and a conformationally constrained PTH(1-21) analog, each containing para-benzoyl-l-phenylalanine (Bpa) at position 19, each cross-linked efficiently to the P1R expressed in COS-7 cells, and digestive mapping analysis localized the cross-linked site to the interval (Leu232-Lys240) at the extracellular end of TM2. Point mutation analysis identified Ala234, Val235, and Lys240 as determinants of cross-linking efficiency, and the Lys240-->Ala mutation selectively impaired the binding of PTH(1-21) and PTH(1-19) analogs, relative to that of PTH(1-15) analogs. The findings support the hypothesis that residue 19 of the receptor-bound ligand contacts, or is close to, the P1R J domain-specifically, Lys240 at the extracellular end of TM2. The findings also support a molecular model in which the 1-21 region of PTH binds to the extracellular face of the P1R J domain as an alpha-helix.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947048     DOI: 10.1210/me.2003-0275

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation.

Authors:  Augen A Pioszak; Kaleeckal G Harikumar; Naomi R Parker; Laurence J Miller; H Eric Xu
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

2.  Conformational changes in the parathyroid hormone receptor associated with activation by agonist.

Authors:  Beena E Thomas; Iwona Woznica; Dale F Mierke; Angela Wittelsberger; Michael Rosenblatt
Journal:  Mol Endocrinol       Date:  2008-02-07

Review 3.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 4.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

5.  Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling.

Authors:  Laurence J Miller; Quan Chen; Polo C-H Lam; Delia I Pinon; Patrick M Sexton; Ruben Abagyan; Maoqing Dong
Journal:  J Biol Chem       Date:  2011-03-16       Impact factor: 5.157

6.  Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore.

Authors:  Maoqing Dong; Polo C-H Lam; Delia I Pinon; Keiko Hosohata; Andrew Orry; Patrick M Sexton; Ruben Abagyan; Laurence J Miller
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

7.  Spatial approximations between residues 6 and 12 in the amino-terminal region of glucagon-like peptide 1 and its receptor: a region critical for biological activity.

Authors:  Quan Chen; Delia I Pinon; Laurence J Miller; Maoqing Dong
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 8.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

9.  Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1).

Authors:  Iman Assil-Kishawi; Tareq A Samra; Dale F Mierke; Abdul B Abou-Samra
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

10.  Mapping peptide hormone-receptor interactions using a disulfide-trapping approach.

Authors:  Paul Monaghan; Beena E Thomas; Iwona Woznica; Angela Wittelsberger; Dale F Mierke; Michael Rosenblatt
Journal:  Biochemistry       Date:  2008-05-07       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.